Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096674
Filing Date
2024-08-14
Accepted
2024-08-14 08:25:42
Documents
72
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ivvd-20240630.htm   iXBRL 10-Q 1839383
2 EX-10.1 ivvd-ex10_1.htm EX-10.1 280076
3 EX-10.3 ivvd-ex10_3.htm EX-10.3 73466
4 EX-10.4 ivvd-ex10_4.htm EX-10.4 71828
5 EX-31.1 ivvd-ex31_1.htm EX-31.1 17360
6 EX-32.1 ivvd-ex32_1.htm EX-32.1 10123
  Complete submission text file 0000950170-24-096674.txt   8100852

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ivvd-20240630.xsd EX-101.SCH 1200170
75 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20240630_htm.xml XML 1188212
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40703 | Film No.: 241204325
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)